2024-12-23 18:48:55
Results of Phase I Clinical Study of Qilu Pharma's PD-1/CTLA-4 Bifunctional Antibody Iparomlimab/Tuvonralimab Published Online in Journal of Hematology & Oncology
Health/ 2023-07-22
Results of Phase I Clinical Study of Qil...

JINAN,China,May 11,2023-- On May 8,2023,the authoritative oncology journal,Journal of Hematology & Oncology (JHO,2022 impact factor of 2...

Kintor Pharma Announces Successful Completion of Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US
Corporate/ 2023-07-24
Kintor Pharma Announces Successful Compl...

SUZHOU,China,May 11,2023-- Kintor Pharmaceutical Limited ("Kintor Pharma",HKEX: 9939),a clinical-stage biotechnology company devel...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release